Detailansicht

Wissensnetz

Person

Christoph Daniel Spinner (1984-)

Internist

Name	Christoph Daniel Spinner
Zeit	1984- (Lebensdaten)
Ort	Offenburg (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med. (an der Medizinischen Fakultät der Universität Freiburg (Breisgau)) (2010)
Beruf	Internist (charakteristischer Beruf)
Variante	Christoph Spinner Christoph D. Spinner
Weitere Angaben	Habil.-Schrift für das Fach Innere Medizin an der Medizinischen Fakultät der Technischen Universität München, 2017
Quelle	Vorlage
Datensatztyp	Person
GND-Nummer	1076755054
Datensatz-ID	1076755054
Beteiligt an alle anzeigen Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany Infektionskrankheiten von A bis Z : Erreger - Klinik - Diagnose - Therapie - Prävention mit aktuellen Impfempfehlungen Declining COVID-19 morbidity and case fatality in Germany: the pandemic end? EVUSHELD (Tixagevimab/Cilgavimab): monoklonale Antikörper gegen SARS-CoV-2 Invasiveness of ventilation therapy is associated to prevalence of secondary bacterial and fungal infections in critically ill COVID-19 patients Klinische und ophthalmologische Charakteristika der okulären Syphilis in einer retrospektiven Kohorte Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ) Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing Retracing the COVID-19 Pandemic in Germany from a Public Perspective using Google Search Queries Related to “coronavirus” Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ) First results of the “Lean European Open Survey on SARS‑CoV‑2‑Infected Patients (LEOSS)” Mucosal-associated invariant T (MAIT) cells are highly activated and functionally impaired in COVID-19 patients Specific risk factors for fatal outcome in critically Ill COVID-19 patients: results from a European multicenter study The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study Clinical management of ageing people living with HIV in Europe: the view of the care providers No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016 Neue Aspekte zur antiviralen Therapie und Prävention der HIV-Infektion

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Christoph Daniel Spinner (1984-)

Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany

Infektionskrankheiten von A bis Z : Erreger - Klinik - Diagnose - Therapie - Prävention mit aktuellen Impfempfehlungen

Declining COVID-19 morbidity and case fatality in Germany: the pandemic end?

EVUSHELD (Tixagevimab/Cilgavimab): monoklonale Antikörper gegen SARS-CoV-2

Invasiveness of ventilation therapy is associated to prevalence of secondary bacterial and fungal infections in critically ill COVID-19 patients

Klinische und ophthalmologische Charakteristika der okulären Syphilis in einer retrospektiven Kohorte

Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing

Retracing the COVID-19 Pandemic in Germany from a Public Perspective using Google Search Queries Related to “coronavirus”

Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients

Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients

Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)

First results of the “Lean European Open Survey on SARS‑CoV‑2‑Infected Patients (LEOSS)”

Mucosal-associated invariant T (MAIT) cells are highly activated and functionally impaired in COVID-19 patients

Specific risk factors for fatal outcome in critically Ill COVID-19 patients: results from a European multicenter study

The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany

The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany

No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020

Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers

Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report

High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study

Clinical management of ageing people living with HIV in Europe: the view of the care providers

No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020

No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020

Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions – Cologne/Bonn, Munich and Hannover, 1999–2016

Neue Aspekte zur antiviralen Therapie und Prävention der HIV-Infektion